WAVE LIFE SCIENCES LTD.

WVE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015
Revenue $3.7M $1.5M $152.0K
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $79.3M $40.8M $9.1M
SG&A Expense $27.0M $16.0M $10.4M
Operating Income $-102.4M $-55.7M $-19.3M
Operating Margin -2,764.3% -3,752.2% -12,696.1%
Interest Expense
Pretax Income $-101.1M $-55.2M $-19.2M
Income Tax Expense $842.0K $482.0K $44.0K
Net Income $-102.0M $-55.7M $-19.2M
Net Margin -2,753.2% -3,748.1% -12,631.6%
EPS (Basic) $-3.85 $-2.44 $-1.83
EPS (Diluted) $-3.85 $-2.44 $-1.83
Shares Outstanding (Basic) 27.8M 23.5M 21.6M
Shares Outstanding (Diluted) 27.8M 23.5M 21.6M
Dividends Per Share
← Newer Page 2 of 2 Older →